Research

Novel prodrug approach to photodynamic therapy: Fmoc solid-phase synthesis of a cell permeable peptide incorporating 5-aminolaevulinic acid


Reference:

Dixon, M. J., Bourre, L., MacRobert, A. J. and Eggleston, I. M., 2007. Novel prodrug approach to photodynamic therapy: Fmoc solid-phase synthesis of a cell permeable peptide incorporating 5-aminolaevulinic acid. Bioorganic & Medicinal Chemistry Letters, 17 (16), pp. 4518-4522.

Related documents:

This repository does not currently have the full-text of this item.
You may be able to access a copy if URLs are provided below.

Abstract

The first example of the synthesis of a peptide incorporating 5-aminolaevulinic acid (5-ALA) using standard Fmoc solidphase chemistry is reported. The synthesised peptide contains residues 52-58 of the cell-permeable peptide Penetratin and represents a prototype for the enhanced topical delivery of 5-ALA using such oligopeptide vectors. Effective intracellular conversion of the peptide to the endogenous photosensitiser, protoporphyrin IX, is observed in PAM212 cells, thus demonstrating the potential of this approach for the development of novel peptide prodrugs for use in photodynamic therapy. (c) 2007 Elsevier Ltd. All rights reserved.

Details

Item Type Articles
CreatorsDixon, M. J., Bourre, L., MacRobert, A. J. and Eggleston, I. M.
DOI10.1016/j.bmcl.2007.05.095
DepartmentsFaculty of Science > Pharmacy & Pharmacology
RefereedYes
StatusPublished
ID Code7636
Additional InformationID number: ISI:000248877800023

Export

Actions (login required)

View Item